Related Experiment Video
Updated: Apr 6, 2026
HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis
Published on: November 11, 2022
Development and validation of an RP-HPLC method for simultaneous determination of sitagliptin and valsartan
Muhammad Waqas1, Muhammad Zaman1, Huma Hameed1
1Faculty of Pharmaceutical Sciences, University of Central Punjab, Lahore, Pakistan.
Background:
Diabetes mellitus and hypertension are commonly coexisting diseases and combination therapies are required to improve therapeutic outcomes and patient compliance.
Objectives:
Current research aims to develop and validate a precise reverse-phase High-Performance Liquid Chromatography (RP-HPLC) method for the concurrent determination of sitagliptin and valsartan.
Methods:
For analysis, an Agilent 1260 Infinity II HPLC system provided with a C-18 column was used. The method was validated as per the ICH guidelines.
Results:
Calibration curves confirmed excellent linearity for sitagliptin and valsartan with RN² values exceeding 0.99. The limits of detection (LOD) and quantification (LOQ) were calculated as 8.5 ppm and 25.7 ppm for sitagliptin and 7.8 ppm and 23.5 ppm for valsartan, respectively. Recovery studies and robustness confirmed method accuracy and indicated no significant impact from small variations in chromatographic parameters.
Conclusion:
In conclusion, this validated RP-HPLC method is consistent and efficient for compliance with pharmaceutical standards.
More Related Videos
06:08Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
